참고문헌
- Selvanayagam JB, Hawkins PN, Paul B, Myerson SG, Neubauer S. Evaluation and management of the cardiac amyloidosis. J Am Coll Cardiol 2007;50:2101-10. https://doi.org/10.1016/j.jacc.2007.08.028
- Falk RH. Diagnosis and management of the cardiac amyloidoses. Circulation 2005;112:2047-60. https://doi.org/10.1161/CIRCULATIONAHA.104.489187
- Kim YJ, Choi SO, Kim MK, et al. A case of familial cardiac amyloidosis. Korean Circ J 2004;34:520-6. https://doi.org/10.4070/kcj.2004.34.5.520
- Berk JL. Pleural effusions in systemic amyloidosis. Curr Opin Pulm Med 2005;11:324-8. https://doi.org/10.1097/01.mcp.0000162378.35928.37
- Grove CS, Lee YC. Vascular endothelial growth factor: the key mediator in pleural effusion formation. Curr Opin Pulm Med 2002;8:294-301. https://doi.org/10.1097/00063198-200207000-00009
- Sack U, Hoffmann M, Zhao XJ, et al. Vascular endothelial growth factor in pleural effusions of different origin. Eur Respir J 2005;25:600-4. https://doi.org/10.1183/09031936.05.00037004
- Pichelmayer O, Zielinski C, Raderer M. Response of a nonmalignant pleural effusion to bevacizumab. N Engl J Med 2005;353:740-1.
- Hoyer RJ, Leung N, Witzig TE, Lacy MQ. Treatment of diuretic refractory pleural effusions with bevacizumab in four patients with primary systemic amyloidosis. Am J Hematol 2007;82:409-13. https://doi.org/10.1002/ajh.20858
- Vogelsberg H, Mahrholdt H, Deluigi CC, et al. Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis. J Am Coll Cardiol 2008;51:1022-30. https://doi.org/10.1016/j.jacc.2007.10.049
- Berk JL, Keane J, Seldin DC, et al. Persistent pleural effusions in primary systemic amyloidosis. Chest 2003;124:969-77. https://doi.org/10.1378/chest.124.3.969
- Smith RR, Hutchins GM, Moore GW, Humphrey RL. Type and distribution of pulmonary parenchymal and vascular amyloid: correlation with cardiac amyloid. Am J Med 1979;66:96-104. https://doi.org/10.1016/0002-9343(79)90488-1
- Bontemps F, Tillie-Leblond I, Coppin MC, et al. Pleural amyloidosis: thoracoscopic aspects. Eur Respir J 1995;8:1025-7.
- Kinasewitz GT. Transudative effusions. Eur Respir J 1997;10:714-8.
- Albertine KH, Wiener-Kronish JP, Staub NC. The structure of the parietal pleura and its relationship to pleural liquid dynamics in sheep. Anat Rec 1984;208:401-9. https://doi.org/10.1002/ar.1092080310
- Light RW, Hamm H. Malignant pleural effusion: would the real cause please stand up? Eur Respir J 1997;10:1701-2. https://doi.org/10.1183/09031936.97.10081701
- Mohammed KA, Nasreen N, Hardwick J, Logie CS, Patterson CE, Antony VB. Bacterial induction of pleural mesothelial monolayer barrier dysfunction. Am J Physiol Lung Cell Mol Physiol 2001;281:L119-25. https://doi.org/10.1152/ajplung.2001.281.1.L119
- Feng D, Nagy JA, Hipp J, Dvorak HF, Dvorak AM. Vesiculo-vacuolar barrier organelles and the regulation of venule permeability to macromolecules by vascular permeability factor, histamine, and serotonin. J Exp Med 1996;183:1981-6. https://doi.org/10.1084/jem.183.5.1981
피인용 문헌
- The Role of Vascular Endothelial Growth Factor in the Pathogenesis, Diagnosis and Treatment of Malignant Pleural Effusion vol.15, pp.3, 2010, https://doi.org/10.1007/s11912-013-0315-7
- Transthyretin Ala36Pro mutation in a Chinese pedigree of familial transthyretin amyloidosis with elevated vitreous and serum vascular endothelial growth factor vol.110, pp.None, 2010, https://doi.org/10.1016/j.exer.2013.02.005
- Closing faucets: the role of anti-angiogenic therapies in malignant pleural diseases vol.18, pp.8, 2010, https://doi.org/10.1007/s12094-015-1464-y